Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Technology
6.1 Introduction
6.2 Wicking technology
6.2.1 Blood glucose meters
6.2.2 Testing stripes
6.2.3 Lancets and lancing devices
6.3 Channel technology
6.3.1 Sensors
6.3.2 Transmitters
6.3.3 Receivers
Chapter 7 Market Segmentation by Distribution channel
7.1 Introduction
7.2 Retail Pharmacies
7.3 Hospital Pharmacies
7.3 Online Pharmacies
Chapter 8 Market Segmentation by Application
8.1 Introduction
8.2 Diabetes
8.2.1 Type 2
8.2.2 Type 1
8.2.3 Gestational Diabetes
Chapter 9 Market Segmentation by Geography
9.1 North America
9.1.1 Introduction
9.1.2 USA
9.1.3 Canada
9.1.4 Mexico
9.1.5 Others
9.2 Europe
9.2.1 Introduction
9.2.2 UK
9.2.3 France
9.2.4 Germany
9.2.5 Italy
9.2.6 Spain
9.2.7 Others
9.3 Asia Pacific
9.3.1 Introduction
9.3.2 Japan
9.3.3 China
9.3.4 India
9.3.5 Australia and New Zealand
9.3.6 South Korea
9.3.7 Others
9.4 South America
9.4.1 Introduction
9.4.2 Brazil
9.4.3 Argentina
9.4.4 Others
9.5 The Middle-East and Africa
9.5.1 Introduction
9.5.2 South Africa
9.5.3 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1 Abbott laboratories
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2 Massachusetts Institute
11.3 Bayer Healthcare AG
11.4 Acon laboratories
11.5 Apex biotechnology corporation
11.6 HMD biomedical
11.7 I-sens Inc.
11.8 Roche diagnostics
11.9 B. Braun Melsungen Ag
11.10 Ascensia diabetes care holdings Ag
11.11 Nihon Kohden Corporation
11.12 Mindray Medical international limited
11.13 Philips Healthcare
11.14 Fukuda Denshi
11.15 Life scan Inc.
Chapter 12 Market Estimates and Forecast
12.1 Market Estimates and Forecast 2018-2024(USD Million)
12.1.1 Market Estimation and Forecast by Technology 2018-2024 (USD Million)
12.1.2 Market Estimates and Forecast by Distribution channel 2018-2024 (USD Million)
12.1.3 Market Estimates and Forecast by Application 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
12.1.5 Market Estimates and forecast by company Profiles 2018-2024(USD million)
Chapter 13 Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
